Navigation Links
Prescription Drug Misuse Remains at Alarming Levels, According to National Study by Quest Diagnostics
Date:4/3/2013

MADISON, N.J., April 3, 2013 /PRNewswire/ -- Despite increased public attention on the epidemic of prescription medication abuse, about three in five Americans tested misused their prescription drugs in 2012, virtually the same as in 2011, according to a national study issued today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.

The new study, believed to be one of the largest to examine trends in the use of commonly abused drugs such as opioid pain killers based on objective laboratory data, suggests a substantial number of patients continue to use their prescribed medications in ways that put their health at risk. The report is now available at QuestDiagnostics.com/HealthTrends.

"Despite public education and publicity surrounding the dangers of prescription drug abuse, our study shows that misuse rates continue to be alarmingly high for opioids and other powerful medications," said F. Leland McClure , Ph.D., director, pain management, mass spectrometry operations, Quest Diagnostics. "We are hopeful that recent efforts by policy makers and public and private health professionals will help to rein in the nation's prescription drug epidemic."

The Quest Diagnostics Health Trends™ report, A Report on Marijuana and Prescription Drug Misuse in America, is based on an analysis of 227,402 de-identified urine lab-test results of patients, age 10 years and older, of both genders in 49 states and the District of Columbia performed by the company's clinical laboratories in 2011 and 2012. The testing was performed in connection with the company's prescription drug monitoring services. These services aid clinicians in monitoring patients for appropriate use of up to 26 commonly abused prescription medications, such as opioids and sedatives, and illicit drugs, such as marijuana and cocaine.

Consistent results indicate that only the drug or drugs prescribed for the patient were detected. Inconsistent results suggest a patient has misused one or more drugs. Forms of misuse include combining a prescribed drug with other non-prescribed drugs, which can lead to dangerous drug combinations; not taking a prescribed drug, which contributes to healthcare waste and failed treatment; and using other drugs, which indicates illicit drug use without a clinician's oversight.

The study's key findings:

  • Drug misuse continues to be highly prevalent, with three in five patients tested still misusing drugs. Sixty percent of patients tested in 2012 misused their medications, a slight improvement over the 63% inconsistency rate of 2011.
  • Marijuana was the most commonly abused drug, followed closely by opioids. Among patients with inconsistent test results in 2012, evidence of marijuana was found in more than one in four (26%) patient test results, followed by opiates (22%), benzodiazepines (16%), oxycodone (14%), cocaine (8%) and methadone (6%).
  • Drug combinations are a common form of misuse. Of patients with an inconsistent test result in 2012, about one in three, or 33%, tested positive for the prescribed drug and at least one additional drug.
  • Substantial numbers of patients did not take their medications. Among patients with inconsistent results, about 42% did not use their prescribed medication, possibly due to forgetfulness, financial constraints or illegal sales.

The study also found that men and women misused prescription drugs equally. Although misuse rates were above 50% for all government and private health plan categories, Medicaid beneficiaries had the highest rates of misuse, at 70%.

"While we had hoped for a noteworthy decline in misuse rates in 2012 compared to 2011, this was not the case," said Harvey W. Kaufman , M.D., senior medical director, Quest Diagnostics. "Not only is prescription drug misuse potentially dangerous for patients, it also contributes to healthcare waste and illegal activity. Our data underscores our nation's need for better solutions for promoting responsible use of prescription drugs."

The U.S. Centers for Disease Control and Prevention attributes 22,134 deaths in 2010 to prescription drug overdoses, a four-fold increase from 1999. 

Quest Diagnostics is a leader in prescription and workplace drug monitoring by diagnostic testing. The company's Drug Testing Index™ is widely considered a benchmark in national trends of drug use by American workers. The company extended its drug monitoring services with the addition of a new portfolio of prescription drug monitoring services for clinicians in 2010.

Study Strengths and Limitations
The study's strengths are its size and national scope; use of an objective laboratory method, versus surveys or polls, which may be subject to user misrepresentation or error; confirmation of all positive drug screens by mass spectrometry, the most advanced drug testing method; and inclusion of patients under care by clinicians in a primary care or pain-management setting, but exclusion of those in drug rehabilitation or addiction treatment settings, where unusually high rates of drug misuse may be expected. 

Study limitations include geographic disparities; inability to confirm drug misuse through access to medical records or clinical evaluation; and technological factors and patient variations, such as drug metabolism and hydration state, that may affect the reliability of a minority of results. Quest Diagnostics does not provide services to all clinicians in the U.S., so results are not broadly representative of all patients taking prescription medications in the U.S. It is also possible some clinicians tested patients due to appropriate suspicions of drug misuse, and that some clinicians omitted to specify all drugs prescribed for the patient on a test order, skewing some results.

The company's Quest Diagnostics Health Trends studies are performed in compliance with applicable privacy regulations, the company's strict privacy policies and as approved by the Western Institutional Review Board.

About Quest Diagnostics Health Trends™ Reports
Quest Diagnostics Health Trends Reports identify trends in disease and wellness based on analysis of de-identified test results from Quest Diagnostics, which maintains the largest private clinical laboratory database in the United States. Quest Diagnostics Health Trends Reports are published in peer reviewed medical journals and by the company as a public service. Previous reports have focused on allergies and asthma, chronic kidney disease, diabetes, heart disease, H1N1 (2009) Influenza, rotavirus and workplace wellness. Visit QuestDiagnostics.com/HealthTrends.

About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/Quest DX.

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.

Quest Diagnostics Contacts:
Wendy Bost (Media): 973-520-2800
Dan Haemmerle (Investors): 973-520-2900


'/>"/>
SOURCE Quest Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
2. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
3. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
4. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
5. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
6. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
7. Partnership Aims to Prevent Students from Misusing Prescription Drugs
8. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
9. New Video, Website Help Health Plan Sponsors, Patients and Policy Makers Maximize Prescription Drug Benefits, Reduce Wasteful Spending
10. President Obama Signs Landmark Accessible Prescription Drug Label Bill
11. Protected Classes Prescription Drug Mandates Would Hike Small Business Costs, Drug Company Profits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the "Dental Implants ... ... for Dental Implants in US$ Million. The report provides separate comprehensive analytics ... , Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2015 through 2022. ...
(Date:3/24/2017)... , March 24, 2017 FinancialBuzz.com News ... ... publisher of cannabis market research, the legal cannabis market is ... through 2021, despite conflicting signals from the current presidential administration. ... that the two biggest drivers of growth in this industry ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Deep ... to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 report examines ... deep learning solutions within the healthcare domain. Primarily driven by the ... solution to generate relevant insights from medical data. ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 24, 2017 , ... “End Time GPS”: a dauntless and enlightened study ... Time GPS” is the creation of published author, Wesley Gerboth, a World War II ... and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon ...
(Date:3/24/2017)... ... , ... “The Communion of Saints: A Pastor’s Potpourri of ... across the United States. “The Communion of Saints” is the creation of ... congregations in seven states throughout his long career of devotion to the church. ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World ... that there could be four million Zika-related cases in the Americas within the next ... of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The physicians of ... in the greater Houston Area. The new location is located at 2255 E. Mossy ... in Springwoods Village. This newest location will provide patients living in the north Houston ...
(Date:3/23/2017)... New Braunfels, TX (PRWEB) , ... March 23, 2017 , ... ... a new clinic, located at 960 Gruene Road in Building 2. The clinic is ... co-owner Dr. Andrew Bennett, PT, says opening the company’s second New Braunfels location brings ...
Breaking Medicine News(10 mins):